ATE205188T1 - Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus - Google Patents

Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus

Info

Publication number
ATE205188T1
ATE205188T1 AT95939672T AT95939672T ATE205188T1 AT E205188 T1 ATE205188 T1 AT E205188T1 AT 95939672 T AT95939672 T AT 95939672T AT 95939672 T AT95939672 T AT 95939672T AT E205188 T1 ATE205188 T1 AT E205188T1
Authority
AT
Austria
Prior art keywords
treatment
insulin
aminoguanidines
carboxylated
diabetes mellitus
Prior art date
Application number
AT95939672T
Other languages
English (en)
Inventor
Scott D Larsen
Valerie A Vaillancourt
Paul D May
Steven P Tanis
John A Tucker
Martin D Meglasson
Heinrich J Schostarez
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/484,547 external-priority patent/US5994577A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE205188T1 publication Critical patent/ATE205188T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95939672T 1994-11-23 1995-11-13 Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus ATE205188T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34427494A 1994-11-23 1994-11-23
US08/484,547 US5994577A (en) 1994-11-23 1995-06-07 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus
PCT/US1995/014126 WO1996016031A1 (en) 1994-11-23 1995-11-13 Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

Publications (1)

Publication Number Publication Date
ATE205188T1 true ATE205188T1 (de) 2001-09-15

Family

ID=26993832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95939672T ATE205188T1 (de) 1994-11-23 1995-11-13 Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus

Country Status (24)

Country Link
US (2) US6166080A (de)
EP (1) EP0793646B1 (de)
JP (1) JPH10509455A (de)
CN (2) CN1097580C (de)
AT (1) ATE205188T1 (de)
AU (1) AU705893B2 (de)
BR (1) BR9509741A (de)
CA (1) CA2202265A1 (de)
CZ (1) CZ288597B6 (de)
DE (2) DE793646T1 (de)
DK (1) DK0793646T3 (de)
EE (1) EE03392B1 (de)
ES (1) ES2163531T3 (de)
FI (1) FI972185A0 (de)
GE (1) GEP20002026B (de)
HU (1) HUT77133A (de)
MX (1) MX9703807A (de)
NO (1) NO308992B1 (de)
NZ (1) NZ297604A (de)
PL (1) PL184614B1 (de)
PT (1) PT793646E (de)
RU (1) RU2162462C2 (de)
SK (1) SK282357B6 (de)
WO (1) WO1996016031A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526331D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel method
AU3117497A (en) 1996-05-21 1997-12-09 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
AU1725197A (en) * 1997-02-13 1998-09-08 Smithkline Beecham Plc Use of nitric oxid synthase inhibitors for the treatment of diabetes
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
SE9702457D0 (sv) * 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6288124B1 (en) 1998-05-22 2001-09-11 Rima Kaddurah-Daouk Methods of inhibiting undesirable cell growth using an aminoguanidine compound
US6169115B1 (en) 1998-05-22 2001-01-02 Rima Kaddurah-Daouk Use of aminoguanidine analogs for the treatment of diseases of the nervous system
US6815421B1 (en) * 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
WO2009133152A1 (en) * 2008-04-29 2009-11-05 Becton, Dickinson And Company Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition
AU2008357111B2 (en) * 2008-06-26 2013-05-09 Laboratorios Silanes, S.A. De C.V. A new metformin Glycinate salt for blood glucose control
GB201300435D0 (en) * 2013-01-10 2013-02-27 Medical Res Council Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
EP3196271B1 (de) * 2015-04-23 2019-01-09 Mitsubishi Gas Chemical Company, Inc. Gaserzeugendes mittel und verfahren zur herstellung eines geschäumten objekts unter verwendung davon
US20170056352A1 (en) * 2015-08-25 2017-03-02 Rgenix, Inc. PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF
WO2018160178A1 (en) 2017-03-01 2018-09-07 Rgenix, Inc. Pharmaceutically acceptable salts of b-guanidinopropionic acid with improved properties and uses thereof
EP4072561A4 (de) 2019-12-11 2023-11-29 Inspirna, Inc. Verfahren zur behandlung von krebs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3412105A (en) 1966-01-05 1968-11-19 American Home Prod beta-aryl-n-guanidino-beta-alanines
US3943253A (en) * 1974-06-27 1976-03-09 Barer Sol J Guanido acids as fungicides
JPS54128523A (en) 1978-03-29 1979-10-05 Nippon Carbide Ind Co Ltd 3-guanidinoamino propionic acid and its preparation
US4758583A (en) * 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
US5130324A (en) * 1984-03-19 1992-07-14 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
US5272165A (en) * 1984-03-19 1993-12-21 The Rockefeller University 2-alkylidene-aminoguanidines and methods of use therefor
IT1201511B (it) 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
US5059712A (en) 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
CZ136997A3 (cs) 1998-02-18
CA2202265A1 (en) 1996-05-30
PL184614B1 (pl) 2002-11-29
BR9509741A (pt) 1997-10-21
DK0793646T3 (da) 2001-12-17
AU705893B2 (en) 1999-06-03
FI972185A7 (fi) 1997-05-22
EP0793646A1 (de) 1997-09-10
CN1164226A (zh) 1997-11-05
CN1097580C (zh) 2003-01-01
JPH10509455A (ja) 1998-09-14
WO1996016031A1 (en) 1996-05-30
AU4279696A (en) 1996-06-17
GEP20002026B (en) 2000-04-10
NO308992B1 (no) 2000-11-27
CN1377642A (zh) 2002-11-06
SK64097A3 (en) 1997-11-05
CZ288597B6 (cs) 2001-07-11
EE03392B1 (et) 2001-04-16
DE793646T1 (de) 1999-12-30
US6166080A (en) 2000-12-26
DE69522580D1 (de) 2001-10-11
NZ297604A (en) 2000-07-28
HUT77133A (hu) 1998-03-02
DE69522580T2 (de) 2002-10-10
FI972185L (fi) 1997-05-22
ES2163531T3 (es) 2002-02-01
MX9703807A (es) 1997-08-30
NO972346L (no) 1997-07-23
EP0793646B1 (de) 2001-09-05
PT793646E (pt) 2002-03-28
US6329545B1 (en) 2001-12-11
RU2162462C2 (ru) 2001-01-27
PL320361A1 (en) 1997-09-29
SK282357B6 (sk) 2002-01-07
NO972346D0 (no) 1997-05-22
FI972185A0 (fi) 1997-05-22
EE9700094A (et) 1997-10-15

Similar Documents

Publication Publication Date Title
ATE205188T1 (de) Carboxylierte aminoguanidine zur behandlung von insulin-unabhängigem diabetes mellitus
ATE238790T1 (de) Verwendung von pramipexole als neuroschutzmittel
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DE69309037D1 (de) Sprüherstarrtes nabumeton
ATE268750T1 (de) Proteintyrosinphosphatase inhibitoren
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
SE9502921D0 (sv) New compounds
DK0730581T3 (da) 3-acylaminobezazepiner
PT722319E (pt) Derivados de antraciclinona e a sua utilizacao no tratamento da amiloidose
ZA891408B (en) Substituted 1,2,4-triazinediones,processes for their preparation and their use
PT989973E (pt) Calconas possuindo actividade antiproliferativa
DE59307799D1 (de) Trägerkatalysator und verwendung desselben
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
AU6918291A (en) Coating material, process for producing it and its use
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
GR3036241T3 (en) METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17-g(b)-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5-g(a)-ANDROST-1-EN-3-ONES.
ATE96319T1 (de) Glycyl-p-amino-pyridin zur behandlung von seniler demenz.
ES2074250T3 (es) Azocolorantes, procedimiento para su preparacion y su empleo.
DE69315672D1 (de) Verwendung von Silikonzusammensetzungen zur Behandlung von Flachdichtungen, insbesondere von Zylinderkopfdichtungen
TH20047A (th) ซูโดเพพไทด์ที่ถูกเอซิเลทชนิดใหม่ที่มีโทรฟลูออโรเมธิล-ซับสทิทิวเทด 2-อะซาไบไซโคลออคเทน
DE69805588D1 (de) Behandlung von lithographischen Druckplattenvorläufern
ZA200103910B (en) 1,4-Diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds.
ATE209493T1 (de) Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression
KR910005761A (ko) 제초제 조성물

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee